Cytek Biosciences, Inc (CTKB) Prices 16.7M Share IPO at $17/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- US stock futures rise after previous session's selloff
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Cytek Biosciences (CTKB) IPO Opens 24% Higher
July 23, 2021 12:10 PM EDTToday's IPO for Cytek Biosciences, Inc. (Nasdaq: CTKB) opened for trading at $21.10 after pricing 6,749,330 shares of its common stock at a price to the public of $17.00 per share.
Morgan Stanley, Goldman Sachs & Co. LLC, Piper Sandler & Co. and Cowen are acting as joint book running managers... More
